Mario Salmona

Citata da

	Tutte	Dal 2019
Citazioni	25986	7216
Indice H	80	45
i10-index	355	176

1400

700

350

1050

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024112 100 88 87 92 100 108 104 137 197 198 252 292 348 363 467 531 603 673 625 717 699 785 678 709 712 866 899 1017 1030 998 1070 1214 1121 1164 1285 1318 1265 1126 1046

Accesso pubblico

Visualizza tutto

80 articoli

13 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Gianluigi ForloniHead of Neuroscience Department IRCCS Mario Negri, MilanEmail verificata su marionegri.it
Fabrizio TagliaviniFondazione IRCCS Istituto Neurologico Carlo Besta, MilanoEmail verificata su istituto-besta.it
Pietro GhezziEx Univ Urbino. Emeritus Prof, Brighton & Sussex Med SchoolEmail verificata su bsms.ac.uk
Roberto ChiesaLaboratory of Prion Neurobiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, MilanEmail verificata su marionegri.it
Alberto MantovaniDirettore Scientifico, Istituto Clinico Humanitas, Humanitas UniversityEmail verificata su humanitasresearch.it
roberto fanellimario negri institute for pharmacological researchEmail verificata su marionegri.it
donati mbHead, Neuromed Biobanking Centre, Department of Epidemiology and Prevention, IRCCS NeuromedEmail verificata su moli-sani.org
Jacopo LucchettiIRCCS - Istituto di Ricerche Farmacologiche "Mario Negri"Email verificata su marionegri.it
Daniel A KirschnerProfessor of Biology, Boston CollegeEmail verificata su bc.edu
Valeria RondelliUniversità degli Studi di MilanoEmail verificata su unimi.it
enrico davoliMario NegriEmail verificata su marionegri.it
Giovanna MuscoS. Raffaele Scientific Institute, Milan, ItalyEmail verificata su hsr.it
Alberti SaverioMedical Genetics, Department BIOMORPH, University of MessinaEmail verificata su unime.it
Giovanni CazzanigaUniv Milano Bicocca - Fondazione TettamantiEmail verificata su unimib.it
Francesco TedescoDepartment of Life Sciences, University of TriesteEmail verificata su units.it
George PerryProfessor of Neuroscience, Developmental and Regenerative Biology and Chemistry, University of TexasEmail verificata su utsa.edu
arne holmgrenprofessor i biokemi , Karolinska InstitutetEmail verificata su ki.se
francesco facchianoEmail verificata su iss.it
Enzo LaurentiUniversita degli Studi di Torino, Department of Chemistry, Torino, ItalyEmail verificata su unito.it
Daniela CurtiAsst. Prof. Neurochemistry, Department of Biology and Biotechnology, University of PaviaEmail verificata su unipv.it

Segui

Mario Salmona

Capo del Dipartimento di Biochimica e Farmacologia Molecolare

Email verificata su marionegri.it - Home page

Proteine amiloidogeniche


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Neurotoxicity of a prion protein fragment G Forloni, N Angeretti, R Chiesa, E Monzani, M Salmona, O Bugiani, ... Nature 362 (6420), 543-546, 1993	1155	1993
Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes M Fratelli, H Demol, M Puype, S Casagrande, I Eberini, M Salmona, ... Proceedings of the National Academy of Sciences 99 (6), 3505-3510, 2002	661	2002
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein C Balducci, M Beeg, M Stravalaci, A Bastone, A Sclip, E Biasini, L Tapella, ... Proceedings of the National Academy of Sciences 107 (5), 2295-2300, 2010	604	2010
Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component B Bottazzi, V Vouret-Craviari, A Bastone, L De Gioia, C Matteucci, G Peri, ... Journal of Biological Chemistry 272 (52), 32817-32823, 1997	526	1997
A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis G Di Fede, M Catania, M Morbin, G Rossi, S Suardi, G Mazzoleni, ... Science 323 (5920), 1473-1477, 2009	506	2009
Regulation of the macrophage content of neoplasms by chemoattractants B Bottazzi, N Polentarutti, R Acero, A Balsari, D Boraschi, P Ghezzi, ... Science 220 (4593), 210-212, 1983	440	1983
Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems S Casagrande, V Bonetto, M Fratelli, E Gianazza, I Eberini, T Massignan, ... Proceedings of the National Academy of Sciences 99 (15), 9745-9749, 2002	426	2002
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35 G Forloni, R Chiesa, S Smiroldo, L Verga, M Salmona, F Tagliavini, ... Neuroreport 4 (5), 523-526, 1993	425	1993
Inhibition of monocyte chemotactic protein-1 synthesis by statins M Romano, L Diomede, M Sironi, L Massimiliano, M Sottocorno, ... Laboratory investigation 80 (7), 1095-1100, 2000	421	2000
CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid R Weigert, MG Silletta, S Spanò, G Turacchio, C Cericola, A Colanzi, ... Nature 402 (6760), 429-433, 1999	415	1999
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products L Diomede, D Albani, M Sottocorno, MB Donati, M Bianchi, P Fruscella, ... Arteriosclerosis, thrombosis, and vascular biology 21 (8), 1327-1332, 2001	390	2001
Anti-amyloidogenic activity of tetracyclines: studies in vitro G Forloni, L Colombo, L Girola, F Tagliavini, M Salmona FEBS letters 487 (3), 404-407, 2001	308	2001
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites M Introna, VV Alles, M Castellano, G Picardi, L De Gioia, B Bottazzai, ...	302	1996
The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide D Albani, L Polito, S Batelli, S De Mauro, C Fracasso, G Martelli, ... Journal of neurochemistry 110 (5), 1445-1456, 2009	294	2009
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide S Mourtas, M Canovi, C Zona, D Aurilia, A Niarakis, B La Ferla, ... Biomaterials 32 (6), 1635-1645, 2011	269	2011
Evaluation of quinacrine treatment for prion diseases A Barret, F Tagliavini, G Forloni, C Bate, M Salmona, L Colombo, ... Journal of virology 77 (15), 8462-8469, 2003	259	2003
Tetracyclines affect prion infectivity G Forloni, S Iussich, T Awan, L Colombo, N Angeretti, L Girola, I Bertani, ... Proceedings of the National Academy of Sciences 99 (16), 10849-10854, 2002	243	2002
Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide M Gobbi, F Re, M Canovi, M Beeg, M Gregori, S Sesana, S Sonnino, ... Biomaterials 31 (25), 6519-6529, 2010	240	2010
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters F Tagliavini, RA McArthur, B Canciani, G Giaccone, M Porro, M Bugiani, ... Science 276 (5315), 1119-1121, 1997	234	1997
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein C Selvaggini, L Degioia, L Cantu, E Ghibaudi, L Diomede, F Passerini, ... Biochemical and biophysical research communications 194 (3), 1380-1386, 1993	234	1993

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori